Literature DB >> 11316368

Distinct levels of genetic diversity of Borrelia burgdorferi are associated with different aspects of pathogenicity.

G Baranton1, G Seinost, G Theodore, D Postic, D Dykhuizen.   

Abstract

Different species of pathogenic Borrelia show different symptoms and tick vector specificity. Even within regions where only one species is found, Lyme disease progresses very differently from one patient to another. Since Borrelia shows very little recombination either within or between species, alleles of a gene can be used to mark clones. The ospC gene is highly variable within each species and can be used to define groups of related clones. It has been previously shown that only four out of seventeen ospC groups of Borrelia burgdorferi sensu stricto cause invasive forms of the disease. Other groups cause erythema migrans, a skin rash at the site of the tick bite, but not invasive disease, while still other groups seem to be nonpathogenic to humans. In this study we extend the analysis of the ospC gene to the other pathogenic species, Borrelia garinii and Borrelia afzelii. Only two groups in B. afzelii and four groups in B. garinii cause invasive disease. Thus, only ten out of the 58 defined ospC groups cause invasive and presumably chronic Lyme disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316368     DOI: 10.1016/s0923-2508(01)01186-x

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  40 in total

1.  Cross-Immunity and Community Structure of a Multiple-Strain Pathogen in the Tick Vector.

Authors:  Jonas Durand; Maxime Jacquet; Lye Paillard; Olivier Rais; Lise Gern; Maarten J Voordouw
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

2.  Epitope mapping of Borrelia burgdorferi OspC protein in homodimeric fold.

Authors:  Adam Norek; Lubomír Janda
Journal:  Protein Sci       Date:  2017-02-11       Impact factor: 6.725

3.  Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of northern Maryland and southern Pennsylvania: lack of correlation with invasive and noninvasive genotypes.

Authors:  Muneera Y Alghaferi; Jennifer M Anderson; Jinho Park; Paul G Auwaerter; John N Aucott; Douglas E Norris; J Stephen Dumler
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Characterization of Borrelia lusitaniae isolates collected in Tunisia and Morocco.

Authors:  Hend Younsi; M'Hammed Sarih; Fatima Jouda; Edmond Godfroid; Lise Gern; Ali Bouattour; Guy Baranton; Daniele Postic
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Humoral immune response associated with lyme borreliosis in nonhuman primates: analysis by immunoblotting and enzyme-linked immunosorbent assay with sonicates or recombinant proteins.

Authors:  A R Pachner; D Dail; L Li; L Gurey; S Feng; E Hodzic; S Barthold
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

6.  Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A.

Authors:  Tero Heikkilä; Ilkka Seppälä; Harri Saxen; Jaana Panelius; Heta Yrjänäinen; Pekka Lahdenne
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

7.  Combined infection of Ixodes ricinus with three Borrelia burgdorferi sensu lato genotypes.

Authors:  K Schwarzová; I Ciznár
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

8.  Comparison of disseminated and nondisseminated strains of Borrelia burgdorferi sensu stricto in mice naturally infected by tick bite.

Authors:  Marc C Dolan; Joseph Piesman; Bradley S Schneider; Martin Schriefer; Kevin Brandt; Nordin S Zeidner
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease.

Authors:  Peter Kraiczy; Annekatrin Seling; Catherine A Brissette; Evelyn Rossmann; Klaus-Peter Hunfeld; Tomasz Bykowski; Logan H Burns; Matthew J Troese; Anne E Cooley; Jennifer C Miller; Volker Brade; Reinhard Wallich; Sherwood Casjens; Brian Stevenson
Journal:  Clin Vaccine Immunol       Date:  2007-12-26

10.  Wide distribution of a high-virulence Borrelia burgdorferi clone in Europe and North America.

Authors:  Wei-Gang Qiu; John F Bruno; William D McCaig; Yun Xu; Ian Livey; Martin E Schriefer; Benjamin J Luft
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.